Synthesis, screening and nanocrystals preparation of rhein amide derivatives

References

• Böhm, B.H. and Müller, R.H., 1999. Lab-scale production unit design for nanosuspensions of sparingly soluble cytotoxic drugs. Pharmaceutical science & technology today, 2, 336–339.
   PubMedGoogle Scholar
• Cai, J., et al., 2012. Bone-targeting glycol and NSAIDS ester prodrugs of rhein: synthesis, hydeoxyapatite affinity, stability, anti-inflammatory, ulcerogenicity index and pharmacokinetics studies. European journal of medicinal chemistry, 55, 409–419.
   PubMed Web of Science ®Google Scholar
• Cao, Y., et al., 2011. Determination of dissociation constents and apparent oil/water partition coefficient of syringopicroside. Chinese journal of experimental traditional medical formulae, 17, 65–67.
   Google Scholar
• Duraipandiyan, V., et al., 2012. Anticaner activity of rhein isolated from Cassia fistula L. flower. Asian Pacific journal of tropical disease, 2, 517–523.
   Google Scholar
• Fu, Q., et al., 2016. Further improvement of oral bioavailability for nisoldipine using nanocrystals. Powder technology, 305, 757–763.
   Web of Science ®Google Scholar
• Gao, Y., et al., 2014. Rhein exerts pro- and anti-inflammatory actions by targeting IKKβ inhibition in LPS-activated macrophages. Free radical biology and medicine, 72, 104–112.
   PubMed Web of Science ®Google Scholar
• Hao, L., et al., 2012. Studies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystals. International journal of pharmaceutics, 433, 157–164.
   PubMed Web of Science ®Google Scholar
• He, Z.H., et al., 2011. Anti-angiogenic effect and mechanism of rhein from Rhizoma Rhei. Phytomedicine : international journal of phytotherapy and phytopharmacology, 18, 470–478.
   PubMed Web of Science ®Google Scholar
• Heo, S.K., et al., 2010. Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production. Vascular pharmacology, 53, 28–37.
   PubMed Web of Science ®Google Scholar
• Jackson, C.L. and Mckenna, G.B., 1990. The melting behavior of organic materials confined in porous solids. Journal of chemical physics, 93, 9002–9010.
   Web of Science ®Google Scholar
• Jiang, T., et al., 2012. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug development and industrial pharmacy, 38, 1230–1239.
   PubMed Web of Science ®Google Scholar
• Karadag, A., Ozcelik, B., and Huang, Q., 2014. Quercetin nanosuspensions produced by high-pressure homogenization. Journal of agricultural and food chemistry, 62, 1852–1859.
   PubMed Web of Science ®Google Scholar
• Kaur, K., Kaur, R., and Dhir, N., 2014. Synthesis and biological evaluation of amino acid and peptide conjugates of rhein derivatives. Journal of advanced pharmacy education & research, 4, 311–318.
   Google Scholar
• Kim, Y.M., et al., 2004. Anthraquinones isolated from Cassia tora (Leguminosae) seed show an antifungal property against phytopathogenic fungi. Journal of agricultural and food chemistry, 52, 6096–6100.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2012. Rhein induces apoptosis of human gastric cancer SGC-7901 cells via an intrinsic mitochondrial pathway. Brazilian journal of medical and biological research, 45, 1052–1059.
   PubMed Web of Science ®Google Scholar
• Lin, H., Qin, F., and Gao, J., 2012. Determination of equilibrium solubility and apparent oil/water partition coefficient of ursolic acid. Chinese journal of modern applied pharmacy, 7, 635–637.
   Google Scholar
• Manosroi, J., et al., 2013. Transdermal absorption and stability enhancement of salmon calcitonin by Tat peptide. Drug development and industrial pharmacy, 39, 520–525.
   PubMed Web of Science ®Google Scholar
• Manosroi, J., et al., 2014. Novel application of polioviral capsid: development of a potent and prolonged oral calcitonin using polioviral binding ligand and Tat peptide. Drug development and industrial pharmacy, 7, 65–70.
   Google Scholar
• Martena, V., et al., 2014. Effect of four different size reduction methods on the particle size, solubility enhancement and physical stability of nicergoline nanocrystals. Drug development and industrial pharmacy, 40, 1199–1205.
   PubMed Web of Science ®Google Scholar
• Mishra, P.R., et al., 2009. Production and characterization of hesperetin nanosuspensions for dermal delivery. International journal of pharmaceutics, 371, 182–189.
   PubMed Web of Science ®Google Scholar
• Mohammed, S.. 2008. The pharmacological actions of naturally occurring 1, 8-dihydroxy anthraquinone derivatives. European journal of organic chemistry, 4, 495–505.
   Google Scholar
• Müller, R.H., Jacobs, C., and Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Advanced drug delivery reviews, 47, 3–19.
   PubMed Web of Science ®Google Scholar
• Peng, Y., Sun, J., and Wang, G., 2009. Pharmacokinetic study of Rhein and its carboxyl-esterification derivatives in rats. Chinese journal of natural medicines, 7, 228–233.
   Google Scholar
• Scholz, P. and Keck, C.M., 2015. Nanocrystals: From raw material to the final formulated oral dosage form-a review. Current pharmaceutical design, 21, 4217–4228.
   PubMed Web of Science ®Google Scholar
• Shah, D.A., Murdande, S.B. and Dave, R.H., 2016. A review: pharmaceutical and pharmacokinetic aspect of nanocrystalline suspensions. Journal of pharmaceutical sciences, 105, 10–24.
   PubMed Web of Science ®Google Scholar
• Su, J., et al., 2013. Chronic allograft nephropathy in rats is improved by the intervention of rhein. Transplantation proceedings, 45, 2546–2552.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2011. Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension. Colloids and surfaces. B, biointerfaces, 83, 189–197.
   PubMed Web of Science ®Google Scholar
• Wang, J., et al., 2015. FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis. Apoptosis, 20, 399–409.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2017. Morphology, in vivo distribution and antitumor activity of bexarotene nanocrystals in lung cancer. Drug development and industrial pharmacy, 43, 132–141.
   PubMed Web of Science ®Google Scholar
• Wei, L., et al., 2015. Preparation, physical characterization and pharmacokinetic study of paclitaxel nanocrystals. Drug development and industrial pharmacy, 41, 1343–1352.
   PubMed Web of Science ®Google Scholar
• Wu, C.H., et al., 2001. Inhibitory effects of Cassia tora L. on benzo[a]pyrene-mediated DNA damage toward HepG2 Cells. Journal of agricultural and food chemistry, 49, 2579–2586.
   PubMed Web of Science ®Google Scholar
• Yang, H., et al., 2014. Investigation of a nanosuspension stabilized by Soluplus1 to improve bioavailability. International journal of pharmaceutics, 477, 88–95.
   PubMed Web of Science ®Google Scholar
• Ye, M., et al., 2013. Synthesis, cytotoxicity, DNA binding and apoptosis of rhein-phosphonate derivatives as antitumor agents. International journal of molecular sciences, 14, 9424–9439.
   PubMed Web of Science ®Google Scholar
• Ye, Y., et al., 2015. Design and evaluation of injectable niclosamide nanocrystals prepared by wet media milling technique. Drug development and industrial pharmacy, 9, 1–9.
   Google Scholar